Resources

Welcome to read and download our industry insights and expert content within the advanced biologics space.

Beyond tomorrow with Janet Hoogstraate

Janet Hoogstraate, CEO of NorthX Biologics, recently appeared in an episode of BEYOND TOMORROW, a podcast by Plantvision. Janet discusses challenges and opportunities within Swedish pharmaceutical manufacturing, with a special focus on ...

Driving therapeutic innovation with OMVs and EVs

Outer membrane vesicles (OMVs) and extracellular vesicles (EVs) are revolutionizing biopharmaceuticals, offering cutting-edge vaccines and therapeutic delivery solutions. These nanoscale vesicles hold immense potential to enhance immune responses and serve ...

Personalized medicine and the CDMO: Adapting to a new era of healthcare

Neoantigen cancer vaccines represent a groundbreaking advancement in personalized medicine, offering tailored cancer treatments designed for each patient’s unique tumor profile. These therapies require rapid turnaround from tumor identification to ...

The Nordics are dancing on

What’s hot and what’s not in ATMP? Insights from service providers, investors, and academics at the 2024 BIO-Europe conference in Stockholm. BIO-Europe celebrated its 30th anniversary in Stockholm, Sweden, on ...

Sweden as a pharmaceutical manufacturing country

Based on a blog post by NorthX Biologics’ CEO Janet Hoogstraate at Stockholm Science City Foundation Sweden holds a unique position in life sciences and has, for decades, been a leading ...

The expanding biologics CDMO market: Innovative modalities and the role of NorthX Biologics

The pharmaceutical industry is experiencing a rapid transformation as advanced biologics – viral vectors, recombinant proteins, plasmid DNA, and cell and gene therapies – take center stage. With over 14,800 ...

Protein science and the future of biotherapeutics

The study of proteins is transforming our understanding of human biology and disease, enabling breakthroughs in diagnostics, drug development, and advanced therapies. In this article, Mathias Uhlén, Professor of Microbiology ...

Podcast with investor Ted Fjällman

NorthX Biologics’ investor and CEO of Flerie, Ted Fjällman made a guest appearance in a recent episode of Värdeskaparna, a podcast taking the audience behind the scenes in the private ...

Q podden with CEO Janet Hoogstraate

Janet Hoogstraate, the CEO of NorthX Biologics, recently appeared in an episode of Q-podden, a podcast on manufacturing, quality and corporate culture in life science. Janet discusses the latest trends and ...

Let’s journey together

NorthX Biologics is dedicated to the journey of complex biologics. Let us know how we can help move your product forward.